- Learn the basics
- Find stocks
- Understand a stock
- Compare with peers
Adlai Nortye Group Ltd.
ANL United States NASDAQAdlai Nortye Ltd. is a clinical-stage biopharmaceutical company that discovers and develops oncology drug candidates. Incorporated in the Cayman Islands, the company conducts research and development activities primarily through subsidiaries in China and the United States. Its pipeline consists of small-molecule and biologic candidates targeting pathways in cancer immunotherapy and targeted therapy, including AN0025, an EP4 antagonist, and AN2025, a pan-PI3K/mTOR inhibitor, along with additional preclinical programs. The company operates in a single business segment focused on the research, development, and potential commercialization of pharmaceutical products for the treatment of solid tumors and hematologic malignancies. It has no approved products and generates no revenue from product sales. Development efforts target regulatory pathways in major pharmaceutical markets, including the United States, China, and other jurisdictions where clinical trials are conducted or planned.
In short
Loading the key numbers…
What the sector means for this company
These sentences describe the numbers; they are not a recommendation. This content is not investment advice.
Price chart: each candle shows one day's opening, highest, lowest and closing price. The projection line is our model's estimate - a model, not a promise.
Price chart
The bars show each projection's high and low scenario. The more likely an outcome, the more solid its half of the bar: for the DCF, how often 400 simulations of the company's growth and margins reach that scenario; for the growth plans, up means the plans succeed and no expected decline hits, down means the plans fail and the declines hit. Switch them off with Ranges.
Key statistics: the most used ratios in one place. Tap the icon next to a name for a short explanation. Compare them with similar companies, not with the whole market.
Financial statements: the income statement shows sales and profit, the balance sheet what the company owns and owes, and the cash flow statement the money that actually came in and went out. How to read them.
Company policy and leadership: an AI-assisted assessment of how the company sells, executes, uses its resources and treats people, production and service. Read it as a starting point for your own research.
News: the latest articles about the company, grouped by day. Each has ratings for the outlet's stance towards the company, how factual it is and the market mood it conveys (an animal label such as Bull or Bear - hover it for the meaning). What the ratings mean.
More Health Care stocks
- Actuate Therapeutics, Inc. (ACTU)
- Acumen Pharmaceuticals, Inc. (ABOS)
- Acurx Pharmaceuticals, Inc. (ACXP)
- Adagene Inc. (ADAG)
- Adagio Medical Holdings, Inc. (ADGM)
- AdaptHealth Corp. (AHCO)
- Adaptive Biotechnologies Corp (ADPT)
- ADC Therapeutics SA (ADCT)
- Addex Therapeutics Ltd. (ADXN)
- Addus HomeCare Corp (ADUS)
- Adicet Bio, Inc. (ACET)
- Aditxt, Inc. (ADTX)
- Adma Biologics, Inc. (ADMA)
- Advanced Biomed Inc. (ADVB)
- AEON Biopharma, Inc. (AEON)
- Aethlon Medical Inc (AEMD)
- Aflac Inc (AFL)
- Agape ATP Corp (ATPC)
- Agenus Inc (AGEN)
- Agilent Technologies, Inc. (A)
- agilon health, inc. (AGL)
- Agios Pharmaceuticals, Inc. (AGIO)
- AIM ImmunoTech Inc. (AIM)
- Airsculpt Technologies, Inc. (AIRS)